Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dafra pharma gmbh - artemether 180mg, lumefantrine 1080mg - co-artesiane is indicated for the treatment of malaria in children, caused by all forms of plasmodium including severe malaria caused by multiple drug resistant strains of p. falciparum. in case of a p. vivax malaria infection an additional treatment with primaquine may be required.

European Union - English - EMA (European Medicines Agency)

amivas ireland ltd - artesunate - malaria - antiprotozoals - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children.consideration should be given to official guidance on the appropriate use of antimalarial agents.

United States - English - NLM (National Library of Medicine)

amivas, inc - artesunate (unii: 60w3249t9m) (.alpha.-dihydroartemisinin - unii:x0uiv26abx) - artesunate for injection is indicated for the initial treatment of severe malaria in adult and pediatric patients. treatment of severe malaria with artesunate for injection should always be followed by a complete treatment course of an appropriate oral antimalarial regimen [see dosage and administration (2.1)] . limitations of use artesunate for injection does not treat the hypnozoite liver stage forms of plasmodium and will therefore not prevent relapses of malaria due to plasmodium vivax or plasmodium ovale . concomitant therapy with an antimalarial agent such as an 8-aminoquinoline drug is necessary for the treatment of severe malaria due to p. vivax or p. ovale [see dosage and administration (2.1)] . known serious hypersensitivity to artesunate, such as anaphylaxis [see warnings and precautions (5.2) and adverse reactions (6.2)] . there are serious risks to the mother and fetus associated with untreated severe malaria during pregnancy; delaying treatment of severe malaria in pregnancy may result in ser

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

dafra pharma gmbh, switzerland - artemether , lumefantrine - suspension, oral - 360mg/120ml + 2160mg/120ml

European Union - English - EMA (European Medicines Agency)

alfasigma s.p.a. - piperaquine tetraphosphate, artenimol - malaria - antiprotozoals - eurartesim is indicated for the treatment of uncomplicated plasmodium falciparum malaria in adults, children and infants 6 months and over and weighing 5 kg or more.consideration should be given to official guidance on the appropriate use of antimalarial agents.

Kenya - English - Pharmacy and Poisons Board

sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - artesunate 100mg + amodiaquine 270mg - tablet - artesunate 100mg + amodiaquine 270mg - antimalarial antiprotozoals: combinations of

Kenya - English - Pharmacy and Poisons Board

sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - artesunate 25mg + amodiaquine 67.5mg - tablet - artesunate 25mg + amodiaquine 67.5mg - antimalarial antiprotozoals: combinations of

Kenya - English - Pharmacy and Poisons Board

sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - artesunate 50mg + amodiaquine 135mg - tablet - artesunate 50mg + amodiaquine 135mg - antimalarial antiprotozoals: combinations of

Kenya - English - Pharmacy and Poisons Board

ipca laboratories limited 48kandivli industrial estatemumbai 400 067 india. - artesunate and amodiaquine tablets. - tablet - artesunate ph.int.50mg … - antimalarial antiprotozoals: plain artemisininand

Kenya - English - Pharmacy and Poisons Board

ipca laboratories limited 48kandivli industrial estatemumbai 400 067 india. - artesunate and amodiaquine tablets. - tablet - artesunate ph.int 100mg … - antimalarial antiprotozoals: plain artemisininand